Review: gene inactivation shaped adaptation in whales, naked mole-rats, hummingbirds and pandas
A review in The Innovation Life collects cases where pseudogenization helped vertebrates adapt, and shows that pseudogene transcripts can protect against or drive human disease.
A review in The Innovation Life examines pseudogenes, gene copies inactivated by mutation and long labelled "junk DNA", in vertebrate adaptation and human disease doi.org
The Innovation Lifedoi.orgOpen source ↗. The authors synthesize recent work on their evolutionary dynamics and functional roles. The human genome alone carries roughly 14,000 pseudogenes. Current identification strategies compare species and screen homologous genes for loss-of-function mutations, which separates genuine gene loss from assembly errors.
Gene loss as adaptation
The review describes a recurring pattern: when a lineage enters a new habitat, genes that once mattered become dispensable, and their inactivation can be adaptive. It assembles cases for immunity, senses, metabolism and diet.
In cetaceans, the bacterial-flagellin receptor TLR5 was pseudogenized. Functional work cited in the review shows that its loss dampens damaging inflammation and improves survival after infection. In the naked mole-rat, underground life relaxed selection on vision: several phototransduction and retinal-integrity genes accumulated inactivating mutations, producing a highly degenerate eye.
In hummingbirds, pseudogenization of FBP2, a muscle-specific gluconeogenic enzyme gene, enhances glycolytic flux, mitochondrial biogenesis and respiratory capacity doi.org
The Innovation Lifedoi.orgOpen source ↗. In the giant panda, loss of DUOX2 coincided with the shift to bamboo, weakening thyroid-hormone synthesis and lowering basal metabolic rate. Loss of the umami receptor T1R1 may have accompanied the same dietary change.
Pseudogenes in human disease
In humans, pseudogenes act mostly through duplicated copies that remain transcribed, via non-coding networks, truncated peptides or cis-regulatory DNA elements. PTENP1, a pseudogene of the tumor suppressor PTEN, sponges microRNAs and lifts repression on PTEN, curbing cancer-cell proliferation. HBBP1 modulates TAL1 and eases beta-thalassemia, while TDGF1P3 transcripts drive tumor progression.
The authors note an asymmetry. Pseudogene-derived regulatory RNAs are well documented in disease but untested in adaptive evolution, largely because adaptation research has centered on unitary pseudogenes and non-model species resist functional experiments. They propose long-read RNA sequencing and CRISPR/Cas9 base editing, which can introduce or revert stop codons, as ways to test causal roles. Convergent pseudogenization in distant species under similar pressures is described as a useful model for the predictability of evolutionary trajectories.
